| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1600-0447.2000.TB10947.X |
| P698 | PubMed publication ID | 11019934 |
| P2093 | author name string | J Zohar | |
| H G Westenberg | |||
| P921 | main subject | serotonin | Q167934 |
| P304 | page(s) | 39-49 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Acta psychiatrica Scandinavica. Supplementum | Q26842026 |
| P1476 | title | Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors | |
| P478 | volume | 403 |
| Q40356863 | 5-HT1A receptor blockade reverses GABA(A) receptor alpha3 subunit-mediated anxiolytic effects on stress-induced hyperthermia |
| Q44428968 | 5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo |
| Q44054638 | Acute effect of ethanol on anxiety and 5-HT in the prefrontal cortex of rats |
| Q44133372 | Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine |
| Q42685211 | Antidepressive-Like Property of Dichloromethane Fraction of Pimenta pseudocaryophyllus and Relevance of Monoamine Metabolic Enzymes |
| Q37216915 | Anxiety disorders in pregnancy |
| Q36552346 | Anxiety in primary care |
| Q44245157 | Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders |
| Q30384567 | Associations of specific phobia and its subtypes with physical diseases: an adult community study. |
| Q37568606 | Biosynthesis of oleamide |
| Q44380472 | Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder |
| Q21260318 | Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study |
| Q41665832 | Comparison of Melatonin and Sertraline Therapies on Tinnitus: A Randomized Clinical Trial |
| Q44911149 | Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. |
| Q39298699 | Depression treatment patterns among adults with chronic obstructive pulmonary disease and depression |
| Q30402366 | Differences in Anxiety-Like Behavior within a Batch of Wistar Rats Are Associated with Differences in Serotonergic Transmission, Enhanced by Acute SRI Administration, and Abolished By Serotonin Depletion. |
| Q37809140 | Drugs involved in drug-facilitated crimes – part II: Drugs of abuse, prescription and over-the-counter medications. A review |
| Q34135689 | Evidence for noncompetitive modulation of substrate‐induced serotonin release |
| Q59329405 | Examination of Current Treatments and Symptom Management Strategies Used by Patients With Mal De Debarquement Syndrome |
| Q37806757 | Gender differences in antidepressant drug response |
| Q56386710 | Generalised anxiety disorder |
| Q34094392 | Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study |
| Q37606260 | Hippocampal serotonin-2A receptor-immunoreactive neurons density increases after testosterone therapy in the gonadectomized male mice. |
| Q46431169 | Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test |
| Q92045098 | Neural function during emotion processing and modulation associated with treatment response in a randomized clinical trial for posttraumatic stress disorder |
| Q34118321 | Paroxetine: an update of its use in psychiatric disorders in adults |
| Q35207551 | Pharmacogenetics of monoamine transporters |
| Q35011794 | Pharmacotherapy of anxious disorders |
| Q88998706 | Plastic change of prefrontal cortex mediates anxiety-like behaviors associated with chronic pain in neuropathic rats |
| Q24195085 | Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults |
| Q38801667 | Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults. |
| Q47623101 | Reflechi twòp--thinking too much: description of a cultural syndrome in Haiti's Central Plateau |
| Q44277552 | Repeated citalopram treatment but not stress exposure attenuates hypothalamic-pituitary-adrenocortical axis response to acute citalopram injection |
| Q35078269 | Role of pharmacogenomics in individualising treatment with SSRIs |
| Q35054424 | Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review |
| Q35173865 | Serotonin and the neuroendocrine regulation of the hypothalamic--pituitary-adrenal axis in health and disease |
| Q47580011 | Serotonin depletion eliminates sex differences with respect to context-conditioned immobility in rat. |
| Q34117810 | Serotonin releasing agents. Neurochemical, therapeutic and adverse effects |
| Q42620907 | Sex-influence of nicotine and nitric oxide on motor coordination and anxiety-related neurophysiological responses |
| Q36926340 | Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine release. |
| Q24655326 | Studies of the biogenic amine transporters. 13. Identification of "agonist" and "antagonist" allosteric modulators of amphetamine-induced dopamine release |
| Q47643932 | The Gain-of-Function Integrin β3 Pro33 Variant Alters the Serotonin System in the Mouse Brain. |
| Q47880684 | The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: Possible relevance for treatment-resistant depression |
| Q35071487 | The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic |
| Q42682241 | The serotonergic projection from the median raphe nucleus to the ventral hippocampus is involved in the retrieval of fear memory through the corticotropin-releasing factor type 2 receptor |
| Q34142899 | Therapeutic and adverse actions of serotonin transporter substrates |
| Q26770334 | Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches |
| Q30428273 | Using the conditioned fear stress (CFS) animal model to understand the neurobiological mechanisms and pharmacological treatment of anxiety |
Search more.